Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2001

View Archived Issues

UPCI announces major effort in the area of lung cancer

NIH licensing opportunity: genes related to prostate cancer

Artecel Sciences awarded two SBIR grants for adipose tissue research

Panacea awarded research grant for Parkinson's disease

Nastech successfully delivers intranasal interferon alfa

GSK and Shionogi to form joint venture for multiproduct development and commercialization

Novel emphysema therapy receives orphan medicinal product designation

Expanded use of Visudyne approved by Canadian authorities

Positive opinion from EMEA moves Foscan closer to approval

High proportion of complete remissions obtained in hairy cell leukemia with new immunotoxin

BioMarin completes phase I clinical trials for rhASB

Phase II study of Neuprex for Crohn's disease set to begin

Favorable pharmacokinetics, pharmacodynamics and safety demonstrated for FFR-rFVIIa in humans

FLT3 tyrosine kinase inhibitor exerts specific cytotoxicity against certain mutated AML blasts

Ilex enters into worldwide license agreement for MUC1 technology

Melanocortin peptides protect against myocardial ischemia in animals

Improving Medicines through Drug Delivery -- Internet Webcast available to Daily Essentials readers

Pegylated formulations of rHuTNF-alpha with improved properties prepared in China

Advanced pulmonary formulation systems: prospects for peptide, protein & systemic drug delivery

New steroid derivatives useful for rheumatoid arthritis, autoimmune diseases

AMPA receptor agonists from ADIR effective in rat models of memory

AstraZeneca claims series with antibacterial activity against Gram-positive microorganisms

Potent and selective PPARalpha activator useful for lowering cholesterol and triglycerides

Thrombopoietin mimetics in the GSK pipeline

Inhaled insulin: a noninvasive mode of drug administration

Colonic drug delivery and the performance and attributes of COLAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...